Basic Information
ID: ALA4262256
Type: Binding
Description: Inhibition of recombinant human DAGLalpha expressed in HEK293 cells using PNP-butyrate as substrate pretreated for 20 to 30 mins followed by substrate addition measured every 60 secs for 20 mins by colorimetric method
Organism: Homo sapiens
Cell type: HEK293
Activity Charts
Bioactivity
Activity Types for Assay ALA4262256
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 422.53 | 5.68 | 5.68 |
| 422.53 | 5.68 | 5.68 |
| 452.35 | 5.13 | 5.13 |
| 466.54 | 4.40 | 4.40 |
| 466.54 | 4.40 | 4.40 |
| 466.54 | 4.40 | 4.40 |
| 452.35 | 5.13 | 5.13 |
| 420.52 | 5.45 | 5.45 |
| 452.56 | 5.65 | 5.65 |
| 450.54 | 5.43 | 5.43 |
| 419.44 | 3.67 | 3.67 |
| 450.54 | 5.43 | 5.43 |
| 466.54 | 5.55 | 5.55 |
| 449.55 | 6.03 | 6.03 |
| 436.52 | 4.42 | 4.42 |
| 374.44 | 3.76 | 3.76 |
| 466.54 | 4.40 | 4.40 |
| 450.54 | 5.43 | 5.43 |
| 368.39 | 3.94 | 3.94 |
| 466.54 | 4.40 | 4.40 |
| 420.52 | 5.45 | 5.45 |
| 449.55 | 6.03 | 6.03 |
| 453.34 | 4.52 | 4.52 |